Dow Up 0.76% Nasdaq Up 0.69%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
15.50 Up 0.09(0.58%) 4:00PM EDT
|After Hours : 15.50 0.00 (0.00%) 5:09PM EDT - Nasdaq Real Time Price
Prev Close:15.41
Open:15.40
Bid:15.60 x 300
Ask:15.63 x 1000
1y Target Est:33.63
Beta:3.45
Earnings Date:Nov 6 - Nov 10 (Est.)
Day's Range:15.20 - 15.99
52wk Range:10.76 - 33.33
Volume:1,837,159
Avg Vol (3m):1,887,360
Market Cap:1.39B
P/E (ttm):N/A
EPS (ttm):-1.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLDX

Comparison

Symbol% ChgMkt Cap
CLDXUp 0.58%1.39B
DNDNDown 0.96%160.09M
LLYUp 2.64%70.79B
RHHBYDown 0.19%248.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):528.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.32
Quarterly EPS Est (Sep-14) :-0.33
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback